BCR_ABL_Universal Real Time PCR Kit

Overview


Applications


  • Precision Treatment Selection in AML:Detection of FLT3-ITD and FLT3-TKD mutations provides actionable genetic insights that guide oncologists and hematologists in selecting appropriate, targeted treatment pathways for acute myeloid leukemia (AML).
  • Therapy Stratification with FLT3 Inhibitors:Supports identification of patients eligible for FLT3 inhibitor therapies, now a standard of care, ensuring accurate matching of treatments to genetic profiles.
  • Clinical Outcome Improvement:Enables timely and precise mutation testing that contributes to optimized therapeutic decisions and improved survival outcomes in AML patients.
  • Molecular Diagnostics for Leukemia Care:Serves as a reliable and efficient diagnostic solution for laboratories delivering high-quality molecular testing to support precision medicine in leukemia management.

Key features & highlights


Mutation Detection

Accurate identification of both FLT3-ITD (via gel-based electrophoresis) and FLT3-TKD (via real-time PCR) in a single integrated workflow.

High Sensitivity & Specificity

Reliable mutation detection with Ct ≤ 35, ensuring high confidence in clinical reporting.

Built-in Internal Control

HEX-labeled probe validates sample integrity and overall workflow performance, minimizing the risk of false-negative results.

Comprehensive Workflow

Combines qPCR screening with confirmatory gel-based analysis, enhancing result robustness and diagnostic accuracy.

Fast & Reliable Turnaround

Delivers reproducible results within hours to support timely clinical decision-making.

Broad Instrument Compatibility

Validated on leading PCR systems including QuantStudio™ 5, Bio-Rad CFX96, Roche LightCycler® 480, and Genes2Me RapiCycler 96.

Ordering Information


Commercial Name Cat No. Pack Size
BCR-ABL Universal Real-Time PCR Ki G2M802721 50 T

Resources to get started


Download useful documents and technical information of BCR-ABL Universal.

Product Enquiry Form


Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.


© 2025 Genes2me. All rights reserved.